Umbilical cord stem cells against macular degeneration. In Italy, a few million people over 50 suffer from it.
Sub-retinal injections of a product derived from umbilical Cord blood have in fact proven capable of slowing down the evolution of this condition. The innovative path attempted by Gemelli, which exploits the regenerative capacity of umbilicals, has been described in Opthalmology Science. The 'dry' form represents 90% of all age-related degenerative maculopathies and to date has no authorized treatment in Europe.